)
Anjali Singh covers the automobile and pharmaceutical sectors, focusing on trends, policy developments, regulatory changes, industry expectations, corporate results among others. A postgraduate in communication journalism, she has a strong inclination towards data-driven reporting and enjoys breaking down complex topics to make them interesting and relevant for readers.
Anjali Singh covers the automobile and pharmaceutical sectors, focusing on trends, policy developments, regulatory changes, industry expectations, corporate results among others. A postgraduate in communication journalism, she has a strong inclination towards data-driven reporting and enjoys breaking down complex topics to make them interesting and relevant for readers.
This optimistic outlook builds on the fact that Swedish companies invested a total of $2.5 bn in India over the last six years, highlighting the expanding economic corridor between the two nations
Sector optimistic that 'supportive policy reforms' will continue, says group
The company said the euro-INR exchange rate has stayed above the Rs 100 mark through 2025, well above historical averages, significantly raising its cost base
forex pressures, rising commodity prices, rural demand uncertainty to push prices up
Zydus will commercialise FYB206 in North America, while Formycon will lead development, regulatory filings and supply, with a US FDA filing expected soon
The JV plans to commercialise 18 semiochemical and pheromone technologies developed by ATGC Biotech in multiple international markets, including Israel, Brazil, Australia and countries in Africa
Indian automakers are reviving legacy nameplates to leverage brand recall and stand out in a crowded market, as classic badges like Sierra, Safari, Baleno and Scorpio return to attract buyers
ASG Eye Hospital will invest Rs 2,000 crore to expand from 175-plus centres to 600-700 by 2030, using acquisitions, new hospitals and district centres, backed by investors
India's largest dialysis provider plans to expand clinics at home and abroad ahead of its December 10 IPO, betting on rising CKD burden and demand for accessible dialysis care
Corona Remedies is pushing into female hormone complex generics to expand beyond India, as its Rs 655.3-crore OFS IPO opens December 8, with a new hormone plant and a stake in La Chandra Pharma Labs
- On paper, machines are deployed daily but residents, workers and vendors say dust still hangs heavy in the air
The civic body said Mumbai's air quality has improved since November 26, supported by ongoing measures and wind speeds rising to 10-18 kilometres per hour
The product, a biosimilar to Amgen's popular drug Neulasta, will be manufactured at Lupin's biotech facility in Pune
Mahindra plans to deploy 1,000 ultra-fast highway chargers by 2027 across 250 major corridors, complementing its growing INGLO-based electric SUV lineup and rising EV production capacity
The Delhi facility offers over 60 advanced tests and aims to close critical gaps in respiratory diagnosis and care
India's two-wheeler industry recorded its best-ever monthly sales in October 2025, buoyed by GST 2.0 rate cuts, festive buying and strong rural demand, with ICRA projecting steady growth for FY26.
Eyes doubling EV volumes in FY26
The company aims to enter 25 cities and capture 10-12 per cent of all last-mile deliveries in these markets
Apollo Hospitals has inaugurated its newest quaternary care centre in Pune, expanding its western India network with advanced specialties, digital systems, and high-acuity services
SAVWIPL has crossed two million locally built vehicles, powered by strong sales, an India-focused platform strategy and rising exports across global markets